Close and careful clinical observation of patients is the very backbone of medical inductive and deductive reasoning, fundamental to establish the paradigms that govern our understanding of health and disease. Such paradigms, once established, are deeply rooted in the psyche and are thus rarely disputed or modified. The paradigm that explains the pathophysiology of acute kidney injury (AKI) is not an exception. Given that the leading clinical conditions associated with AKI, namely, sepsis, major surgery, heart failure, and hypovolemia (1), are all associated with shock, it is tempting to attribute all AKI to ischemia on the basis of macrohemodynamic changes. However, an increasing body of evidence suggests that AKI can occur in the absence of overt signs of hypoperfusion, either global or regional. For instance, a large-scale study that included more than 1,800 patients with confirmed diagnosis of pneumonia found that AKI was common among patients with nonsevere pneumonia, including those who were never admitted to the intensive care unit nor had any evidence of hemodynamic instability (2). Despite the limitation of being unable to address whether transient periods of hypotension occurred, the fact that these patients never required escalation of care suggests that AKI can occur in the absence of overt signs of shock and, more importantly, in the population that the medical community would not classify as “at risk” (2). In addition, despite wide controversy about the role of global renal blood flow (RBF), animal models and human studies have shown that the occurrence of sepsis-induced AKI is not exclusive of decreased RBF states, and that, on the contrary, can develop in the setting of increased RBF (3, 4). Not only can AKI occur in the absence of macrohemoynamic signs of hypoperfusion, but also it seems that whole-body warm ischemia may not be sufficient to cause it either. Of interest, only a very small proportion of patients after cardiac arrest, a natural “model” of warm ischemia, develop AKI, and those who do are patients who develop cardiogenic shock in the postarrest period (5). These results are reminiscent of animal studies that failed to induce AKI in the setting of hemorrhagic shock (6, 7). Finally, in vitro studies using cell cultures, in which hemodynamics are no longer relevant, have shown that many of the cardinal features of sepsis-induced AKI can be reproduced in human epithelial tubular cells by exposing them to plasma from septic patients (8). These data provide evidence that, at least in some patients, renal injury cannot be explained solely on the basis of the classic paradigm of hypoperfusion and that other mechanisms must come into play. This review focuses on the potential mechanisms that could explain the occurrence of AKI in the absence of tissue hypoperfusion.
One of the limitations in advancing the understanding of sepsis-induced AKI is the lack of pathologic specimens available in this patient population, given that, as a consequence of the inherent risks, biopsies are almost never performed. Clinical studies based on physiologic data and few recent postmortem reports have started to define what sepsis-induced AKI actually looks like and how it differs from other types of kidney injury. Histologically, sepsis-induced AKI has been typified by patchy, heterogeneous tubular cell injury with apical vacuolization, but with absence of tubular necrosis or even extensive apoptosis (9). Importantly, all these features develop in the context of renal vasodilatation and normal or increased RBF (10–15) and frame the clinical phenotype characterized by a profound decrease in glomerular filtration rate (GFR), creatinine clearance, and the development of uremia.
Although cell death (either via necrosis or apoptosis) is not a prominent feature of sepsis-induced AKI, a consistent observation in septic humans and animals, regardless of disease stage, severity, or organ examined, appears to be the presence of three main alterations: inflammation (16, 17), diffuse microcirculatory flow abnormalities (18), and cell bioenergetic adaptive responses to injury (19). The study and understanding of these three domains in terms of the relationship between them, their relative contribution to the development of tubular injury and AKI, may provide a roadmap to unravel the mechanisms by which sepsis causes AKI and perhaps organ injury in general and may facilitate the development of more targeted therapies. These three domains frame a unifying theory that we are proposing.
A POSSIBLE UNIFYING THEORY
Functionally, sepsis-induced AKI manifests as a dramatic decline in GFR and variable tubular dysfunction. However, the histological footprint does not entirely explain this functional phenotype. It is characterized by the presence of nonspecific, patchy areas of tubular cell vacuolization and a remarkable absence of apoptosis or necrosis (20). Current evidence suggests that the origin of most cases of AKI is multifaceted rather than the result of an individual insult and that several, concurrent mechanisms may be at work. These mechanisms include inflammation, profound, heterogeneous distortion of microvascular flow at the peritubular and glomerular levels and stimulation of mitochondrial quality control processes and cell cycle arrest. Given that these three major players occur early in the course of sepsis, we propose the following theory to explain the pathophysiology of sepsis-induced AKI.
We conceptualize sepsis-induced AKI as the early clinical and biochemical manifestation of an adaptive response of the tubular cells to an injurious, inflammatory danger signal. We submit that the interplay of inflammation and microvascular dysfunction characterizes and amplifies this signal and that, in response, mitochondria within tubular cells orchestrate a complete metabolic downregulation and reprioritization, which favors individual cell survival processes (such as maintenance of membrane potential and cell cycle arrest), at the expense of “kidney function” (i.e., tubular absorption and secretion of solutes).
The “danger” signal: amplification by microvascular dysfunction and impact on the tubular epithelial cell
During sepsis, inflammatory mediators derived from pathogens and activated immune cells (i.e., lipopolysaccharide [LPS], cytokines, etc., also known as damage- or pathogen-associated molecular patterns [DAMPs/PAMPs]), which prime, signal, alert, and guide the immune system to fight infection, also mediate host cellular injury. Damage-associated molecular patterns and PAMPs can be recognized not only by cells of the immune system, but also epithelial and parenchymal cells, through pattern recognition receptors. These include Toll-like receptors (TLRs), NOD-like receptors, and RIG-I–like receptors (21). The fact that the kidney receives 20% of the cardiac output and filters about 120 to 150 mL of plasma every minute places it on the front line to be exposed to such mediators. Either DAMPs and PAMPs can exert their effects on the renal tubular cells via the peritubular microcirculation, or they can be filtered at the glomerulus (Fig. 1). It has been recently demonstrated that these molecules can be recognized by tubular cells through TLR-4 (and TLR-2)–dependent pathways (Fig. 2) (22). Despite that potentially all nephrons in the kidney could be exposed to these mediators, only patches of tubular cells seem to display signs of distress to this “danger signal” (23). This patchy appearance closely resembles the heterogeneous distribution of flow because of microvascular dysfunction, and we speculate that these two events may be causally related. We further venture that microvascular dysfunction may play a key role in amplifying the “danger signal” in specific areas of low flow, exposing neighboring tubular epithelial cells and causing damage in the observed patchy distribution.
Sepsis causes a profound alteration in microvascular blood flow distribution throughout the body. This abnormality is characterized by increasing heterogeneity of flow. Anatomically, a significant decrease in capillary density occurs. Functionally, there is a decrease in the proportion of capillaries with “nutritive” or continuous blood flow, along with a concomitant increment in the proportion of capillaries with intermittent or no flow (24–26). The renal microcirculation is altered in a similar fashion, as has been recently described in different models of sepsis-induced AKI. These alterations have been predominantly characterized by a decrease in vessels with continuous flow (17, 27, 28) and a concomitant increase in vessels with intermittent or no flow.
Although not the focus of this review, it is important to underscore two important processes. The first is that such a microcirculatory alteration may create areas of hypoperfusion and hypoxia (29, 30) in parallel to the mechanisms that we will describe and that these loci of hypoxia may contribute to the inflammatory process and to the adaptive metabolic downregulation of the renal tubular cell through a process known as oxygen conformance (31). The second is the potential role of nitric oxide (NO) in the genesis of microvascular dysfunction and in the pathophysiology of AKI. Although it is known that sepsis elicits a global increment in production of NO (32), the expression of one of the most important catalyzers of its production, inducible NO synthase (iNOS), is heterogeneous (32). Therefore, it is reasonable to consider that heterogeneous expression of iNOS may result in heterogeneous regional concentrations of NO, which could potentially lead to pockets of vascular beds deprived of NO even in the setting of elevated systemic levels (33). This is important as it directly relates to the heterogeneous pattern that has been described in sepsis-induced microvascular dysfunction and furthermore may relate to possible pathophysiologic phenomena such as shunting and hypoxia (33). Nevertheless, the relationship between NO, microvascular dysfunction, and AKI may not be as straightforward, as sepsis may also cause an iNOS-dependent decrease in endothelial-derived NO synthase activity, which would also result in impaired microvascular homeostasis (34, 35). Finally, selective inhibition of iNOS not only can restore the renal microcirculatory derangements brought about by sepsis, but also is associated with decreased histological and functional manifestations of renal injury, suggesting that microcirculatory abnormalities may be in the mechanistic pathway of sepsis-induced AKI (27).
Amplification of the signal: association between sluggish flow and tubular oxidative stress
Sepsis-induced microvascular dysfunction produces areas of sluggish peritubular flow, which seems to be central to the amplification of the inflammatory signal. In support of this, Holthoff et al. (28) showed that red blood cell velocity is severely decreased 6 h after cecal ligation and puncture (CLP) in these dysfunctional capillaries. Just as with the red blood cells, activated leukocytes passing through these areas of sluggish microvascular flow also decrease their velocities and increase their transit time as demonstrated by Goddard et al. (36) in myocardial capillaries during a porcine model of endotoxemia. In addition, there is evidence of upregulation of inflammatory molecules, such as intercellular adhesion molecule 1 and vascular cell adhesion molecule 1 (37, 38), in these peritubular capillaries that would contribute to prolonged leukocyte transit and increased signaling with kidney dendritic cells (Fig. 2). This prolonged transit may directly translate into a greater time of exposure of the endothelium and neighboring tubular epithelial cells to activated, cytokine secreting leukocytes and to other PAMPs and DAMPs that ultimately amplify the inflammatory signal and cause greater oxidative stress. The tubular epithelial cells exposed to this amplified signal then act as primary targets for this alarm; respond to it by undergoing oxidative stress, vacuolization, and adaptation to the microtubular environment; and ultimately signal other tubular cells to shut down in a paracrine fashion (see below). Importantly, this provides an explanation for why only a few heterogeneous groups of tubular epithelial cells demonstrate the typical histopathologic changes (Fig. 2).
Oxidative stress, a hallmark of sepsis-induced tubular injury, is an early event that is spatially associated with these areas of sluggish flow. Already within 4 h after CLP reactive oxygen (ROS) and nitrogen (RNS) species concentrations increase, predominantly localized to tubules bordered with no capillary blood flow, suggesting sluggish/stop flow may not only be an epiphenomenon, but rather part of the causation pathway (16, 17). Furthermore, using intravital microscopy and epi-illumination to detect surface contour, oxidative stress has been localized to apical vacuoles (23). This is important, because one of the very few histopathologic features that are uniformly identified in animal and human sepsis-induced AKI has been apical epithelial tubular cell vacuolization. In addition, the temporal association between these phenomena suggests a mechanistic link to how this may develop as peritubular capillary dysfunction, and the expression of intercellular adhesion molecule 1 and vascular cell adhesion molecule 1, epithelial cell oxidative stress, and “renal failure” (as measured by functional assays blood urea nitrogen [BUN] and creatinine) occurred at 2, 4, and 10 h, respectively.
Although hypoxia may contribute to tubular injury and inflammation and induce an adaptive response (23, 39, 40), we theorize that this is not the only mechanism and that DAMP-induced inflammation and oxidative stress through TLR-4 activation may be at least as important.
The response to danger: tubular metabolic downregulation and reprioritization of cellular functions
The tubular cell response to this rarefied peritubular microenvironment seems to be adaptive in origin. The bland histology and the surprising paucity of apoptosis and necrosis in septic kidneys support this notion and have led to the understanding that sepsis-induced AKI does not follow the same injury pattern as ischemia-reperfusion and hemorrhage and that it is not characterized by acute tubular necrosis (9). On the contrary, the tubular epithelial cell appears to limit processes that can otherwise activate apoptotic and necrotic signaling pathways, notably energy imbalance and DNA damage. Accordingly, we propose that the initial insult to the tubular epithelial cell is framed by inflammation and oxidative stress and that this triggers an adaptive response characterized by suppressing energy turnover, downregulating metabolism through prioritization of energy consumption (19, 41–43), and undergoing cell cycle arrest (Fig. 3) (44). We submit that this response, orchestrated by mitochondria (see below), limits further injury by maintaining energy balance and preventing further DNA damage and is central to providing the cell with an opportunity to regain function once danger has abated.
Oxidative stress, inflammation, and the trigger of the adaptive response
There is evidence to suggest that sepsis-induced oxidative stress is related not only to histopathologic findings, but also to tubular dysfunction. Gupta et al. (45) showed that, in the presence of LPS, proximal tubules of mice have a delayed uptake of low-molecular-weight dextran, a sign of reduced endocytic capacity. Furthermore, Good et al. (46) have shown in an LPS-induced rodent sepsis model that LPS inhibits NHE1 (Na+/H+ exchanger 1) and thus blocks bicarbonate reabsorption in the medullary thick ascending limb of the loop of Henle.
In addition, this oxidative stress response seems to be the result of an organized interaction between DAMPs and PAMPs and the tubular epithelial cell rather than a random event. Damage-associated molecular patterns and PAMPs originating from remote sites of injury or infection can gain access to the renal tubules by glomerular filtration or by proximity to the peritubular capillaries (47). Furthermore, sepsis induces renal-wide expression of otherwise constitutively expressed TLR-4 (48), and DAMPs/PAMPs are actively recognized by tubular epithelial cells through TLR-4 (22). Kalakeche et al. (22) have elegantly shown that TLR-4–dependent LPS recognition in the tubular epithelial cells occurs in the S1 segment of the proximal tubule, that assembly of LPS with TLR-4 in the tubular epithelial cell produces internalization of LPS through fluid-filled endocytosis, and that this triggers an organized oxidative outburst in epithelial cells of the adjacent tubular segments (S2 and S3) but not in the S1 segment (Fig. 2) (22). These findings have led Kalakeche et al. (22) to suggest that the S1 segment of the proximal tubule acts as a “sensor of danger” that activates a series of events resulting in oxidative stress within distal tubular segments (S2, S3) and that could potentially explain tubular dysfunction in the setting of sepsis. We further hypothesize that this oxidative outburst is the trigger for the adaptive response of the tubular epithelial cell, which is characterized by reprioritizing energy expenditure, downregulating metabolism, and undergoing cell cycle arrest (Fig. 3).
The adaptive response of the tubular epithelial cell to sepsis-induced injury
Apoptosis is the principal mechanism of programmed cell death in multicellular organisms (49). It can be triggered by a myriad of stimuli including DNA damage, energy failure, growth factor deprivation, and endoplasmic reticulum stress (49), all of which also occur as a consequence of sepsis. Yet, tubular cell apoptosis is largely absent in patients with sepsis-induced AKI. It is likely that the scarcity of apoptosis is mainly orchestrated by mitochondria, as these organelles are central in the process of triggering the programmed cell death machinery (50). Importantly, mitochondria influence three key processes that could potentially lead to apoptosis: (a) energy homeostasis and prioritization of energy consumption, (b) maintenance of cellular organelle function through quality control processes (general autophagy and mitophagy), and (c) cell cycle and DNA replication. We submit that these processes not only are fundamental aspects of the adaptive response of the tubular epithelial cell, but also explain, at least in part, the sepsis-induced AKI phenotype.
Reprioritization of energy consumption
Atkinson (51) was the first to propose that ATP consuming processes should have a hierarchy of response dependent on the level of energy charge (ATP) or energy supply, and Buttgereit and Brand (52) provided evidence of this for the first time in stimulated thymocytes. As predicted by Atkinson (51), they showed that certain pathways such as macromolecular synthesis and transmembrane sodium and chloride cycling were more sensitive to changes in energy supply. Buck et al. (53) showed that a similar process occurs when cells are exposed to hypoxia. In turtle hepatocytes, hypoxia induced a hierarchical downregulation of major “energy sinks” such as protein synthesis and was capable of suppressing energy consumption 10-fold. Importantly, processes that were necessary for cell survival, such as maintenance of cytosolic membrane potential and integrity (Na/K ATPase), were the least suppressed. Thus, ATP supply by mitochondria actively regulates energy turnover, avoiding energy expenditure in “nonessential” pathways and allowing the cell to prioritize energy consuming in essential processes such as maintenance of ion gradients (54). This is a highly conserved mechanism across species that seems to frame the core strategy of cellular response to threatening circumstances. It also provides the conceptual ground to suggest that cellular metabolic downregulation and reprioritization of energy consumption are pillars of the tubular epithelial response to sepsis and furthermore explains why organ function is sacrificed in benefit of individual cell survival (45, 46).
Autophagy (and the specialized process of mitochondrial removal called mitophagy) is an evolutionarily conserved, quality control mechanism, by which eukaryotic cells remove and digest dysfunctional organelles from the cytoplasm (55, 56). During sepsis, TLR-4–mediated inflammation (57), oxidative stress (58, 59), and alterations in the electron transport chain that “uncouple” respiration from ATP production and depolarize the mitochondrial membrane are potent triggers of mitophagy (56). This early mitochondrial uncoupling characterized by an increment in O2 consumption (VO2) is not to be confused with the adaptive response it triggers, which is framed by the activation of mitophagy, and is characterized by a decrement in VO2 and conservation of energy.
In the kidney, mitophagy is activated as early as 3 h after CLP-induced sepsis (60), suggesting it is part of the early response of tubular epithelial cells to injury. Importantly, the time-dependent decline in mitophagy has been associated with proximal tubular dysfunction with decreased sodium transport and creatinine clearance and increased BUN and creatinine (60). Finally, insufficient activation of mitophagy has been associated with worse outcome in critically ill patients, and it has been postulated to contribute to cell and organ dysfunction (61).
On the other hand, stimulation of autophagy has been shown to be effective at protecting organ function. Gunst et al. (61) showed in critically ill rabbits that treatment with rapamycin (a potent inductor of mitophagy) was associated with protection of renal function. Similarly, Hsiao et al. (60) showed that preincubation of NRK-52E cells (proximal tubule epithelial cell line) with rapamycin prevented tumor necrosis factor α–induced cell death, whereas inhibition of autophagy exaggerated it. Furthermore, they demonstrated in CLP-induced septic rats that a decline in autophagy was associated with increased BUN and creatinine and a decline in proximal tubular sodium transport (60).
As a protective response, mitophagy offers several advantages, namely, removal of dysfunctional mitochondria, with subsequent decrement in ROS/RNS production and energy conservation, as “nonessential” energy consumption from uncoupled respiration is reduced, and lipids and proteins are recycled for ulterior use as a source of energy. Importantly, these benefits may limit oxidative stress damage and intercept proapoptotic signals at the mitochondrial level impeding triggering of apoptosis (56). Finally, there is also evidence that cross-talk between autophagy and apoptosis does occur, as they both share common factors, interconnections, and regulatory steps (62–64).
It is unknown, however, what mitophagy-induced maintenance of renal function really means. The adaptive response, framed by metabolic downregulation and prioritization of energy consumption, would most likely decrease tubular and renal function and not promote it, just as hibernation promotes functio laesa. Indeed, increased or preserved renal function in the setting of stress may result harmful in the long run. Yet, animal and human data associate acute stimulation of autophagy with preserved renal function, and its faulty activation or decline with worse outcome. It is possible that the interplay of autophagy and tubular cell function varies with time and that persistence of the initial protective response may ultimately be deleterious in the subacute or chronic phases.
Cell cycle arrest
There is a growing body of evidence indicating that mitochondria are intimately involved in the regulation of the cell cycle (56). The ability of mitochondria to move within the cell, change shape, and coalesce in different ways has recently emerged as an important feature, which may affect the cell cycle (65). Briefly, the cell cycle is the progression of cells through a number of steps in preparation for mitosis (G0, G1, S, G2, M). This preparation portrays several checkpoints in which the cell seems to evaluate whether it is prepared to advance to the next phase. Of particular interest to renal tubular injury in sepsis and the involvement of mitochondrial regulation is the G1-S checkpoint. Growing cells appear to have a mixture of tubular and fragmented mitochondria, whereas cells at the G1-S margin display a single, tubular network of mitochondria. This mesh seems to be transient and specific to the G1-S transition, and mitochondria in this structure seem to act as syncytia, with electrical coupling and unusual hyperpolarization (66). These findings fit well with prior studies showing an increase in O2 consumption during the G1-S transition of the cell cycle (67). This also relates to the finding that a reduction in ATP production induced by specific ETC mutations produces cell cycle arrest at the G1-S checkpoint (68). Together, these data indicate that the formation of this giant tubular network is necessary to meet the energy requirement needed to synthesize all the components for adequate cell division. It also suggests that the G1-S border is an important checkpoint of the cycle and that the inability to meet such energy requirements triggers pathways that lead to cycle arrest preventing the cell from undertaking a process that could represent a lethal energy imbalance (65). Yang et al. (44) recently showed in a rodent model of CLP-induced sepsis that G1-S cell cycle arrest was associated with kidney injury and that recovery of renal function paralleled cell cycle progression 48 h after CLP. These findings have become even more clinically relevant as tissue inhibitor of metalloproteinases 2 (TIMP-2) and insulinlike growth factor–binding protein 7 (IGFBP-7), two markers involved in G1-S cycle arrest, have been identified as the most sensitive and specific markers to predict risk of development of AKI in critically ill patients (69). We speculate that the renal cell cycle arrest in the epithelial tubular cell may provide an advantage by avoiding replication for the following reasons: (a) limiting cell replication conserves energy levels and prevents the cell from undergoing an energetically overtaxing endeavor that could potentially trigger apoptosis and (b) limiting replication diminishes the probability of DNA damage, which reduces the chances of triggering apoptosis and also conserves energy by sparing the cell from repairing damaged DNA.
How are tubular injury and GFR related?
Finally, although these mechanisms may provide a clear explanation of how sepsis may induce tubular damage, they fail to link early tubular injury with the massive decline in GFR. Conversely, inflammation-mediated microvascular dysfunction, extraglomerular shunting, and capillary dropout may serve to explain why GFR is reduced during sepsis-induced AKI, but fail to explain why tubular injury occurs or how these phenomena relate to each other. The strong association between these two phenotypic signatures of sepsis-induced AKI makes a single mechanism more likely than separate mechanisms acting independently. A likely mechanism linking both phenomena is tubuloglomerular feedback (TGF). Sepsis-induced tubular injury and dysfunction (45, 46, 60) may interfere with Na+ reabsorption through the Na/K/2Cl cotransporter in the proximal tubule (70), increase the load of NaCl delivered to the macula densa, and thus trigger TGF (Fig. 3). Activation of TGF would decrease hydrostatic pressure in the glomerulus and thus decrease GFR. Importantly, all of the adaptive changes in tubular cell function discussed above are entirely consistent with this scenario and serve to underscore the linkage between tubular cell biology and glomerular function.
Potential therapeutic targets
One of the most important advantages of understanding the mechanistic underpinnings of a disease process is the possibility it offers to find novel and, more importantly, effective therapeutic interventions. In no other disease process, affecting the critically ill, is this more true than in sepsis. For decades, therapeutic efforts have failed to significantly reduce mortality. The unifying theory presented herein provides a possible roadmap to unraveling the pathophysiology of sepsis-induced AKI, a known driver of mortality in this population. Furthermore, if proven, new avenues to attack this disease process, at different stages, may be opened. Indeed, stage-specific manipulation of inflammation, microvascular dysfunction, and of cellular energy regulation may provide a new way to prevent and/or treat sepsis-induced AKI and possible other sepsis-induced organ failures. The recognition of the derangement in microcirculatory flow, for example, has triggered the investigation of therapeutic strategies to understand how to maintain or reestablish microvascular autoregulation that would have never been conceived should this not have been recognized. For example, the use of vasodilators in the setting of sepsis is currently under investigation including use of systemic vasoactive medications (71–75), modulation of NO production, exogenous NO administration, and protection of the endothelial cell in the context of inflammatory activation (30, 33, 35, 76, 77). In the same way, animal data have suggested that stimulation of evolutionarily conserved, intrinsic cellular mechanisms that regulate energy utilization and quality control processes may result in organ protection in the setting of sepsis-induced AKI (78). Indeed, the conservation and promotion of autophagy have been shown to be associated with better prognosis in septic animals and humans (55, 61). In summary, we believe that this unifying theory may shed light on possible future targets for intervention, destined to protecting the microvasculature and the endothelium, balancing energy utilization and modulating inflammation.
We have put forward a possible “unifying theory” of the pathogenesis of sepsis-induced AKI, framed by the concept that the clinical phenotype is predominantly the early expression of an adaptive response of the tubular cells to an injurious, inflammatory danger signal. We submit that the interplay of inflammation and microvascular dysfunction characterizes and amplifies this signal and that, in response, mitochondria within tubular cells orchestrate a complete metabolic downregulation and reprioritization of energy utilization, which favors individual cell survival processes (such as mitophagy and cell cycle arrest), at the expense of “kidney function” (i.e., tubular absorption and secretion of solutes).
The concepts of the pathogenesis of sepsis-induced AKI, although still incompletely understood, have suffered profound change in recent years. It seems that modern conceptualization of the disease process has abandoned the notion of equating sepsis-induced AKI to acute tubular necrosis. Furthermore, despite that hypoxia remains rightfully embedded in the core of the pathophysiologic rationale, there has been a healthy recognition that the processes that lead to sepsis-induced AKI may perhaps be more complex than previously thought and that involve other important mechanisms. The work of many has provided solid foundations to this modern thinking and has also laid the necessary knowledge and tools to better appreciate the roles of these key processes.
We emphasize that this “unifying theory” is not a universal theory, and thus, many other potentially important processes have not been considered. Nevertheless, the data hereby presented may provide new avenues of investigation that will hopefully lead to unraveling the mechanisms by which sepsis induces AKI and, better yet, mechanistic patterns that govern global organ dysfunction in this setting that may facilitate the development of more and better targeted future therapies.
The authors thank Dr Michael R. Pinsky, Brian Zuckerbraun, and Alonso Gomez for their valuable input in the conception of this theory and review of this article.
1. Uchino S, Kellum JA, Bellomo R, et al.: Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA
294 (7): 813–818, 2005.
2. Murugan R, Karajala-Subramanyam V, Lee M, et al.: Acute kidney injury
in non-severe pneumonia is associated with an increased immune response and lower survival. Kidney Int
77 (6): 527–535, 2010.
3. Langenberg C, Wan L, Egi M, May CN, Bellomo R: Renal blood flow in experimental septic acute renal failure. Kidney Int
69 (11): 1996–2002, 2006.
4. Langenberg C, Bellomo R, May C, Wan L, Egi M, Morgera S: Renal blood flow in sepsis
. Crit Care
9 (4): R363–R374, 2005.
5. Chua HR, Glassford N, Bellomo R: Acute kidney injury
after cardiac arrest. Resuscitation
83 (6): 721–727, 2012.
6. Zager RA: Partial aortic ligation: a hypoperfusion model of ischemic acute renal failure and a comparison with renal artery occlusion. J Lab Clin Med
110 (4): 396–405, 1987.
7. Cerchiari EL, Safar P, Klein E, Diven W: Visceral, hematologic and bacteriologic changes and neurologic outcome after cardiac arrest in dogs. The visceral post-resuscitation syndrome. Resuscitation
25 (2): 119–136, 1993.
8. Mariano F, Cantaluppi V, Stella M, et al.: Circulating plasma factors induce tubular and glomerular alterations in septic burns patients. Crit Care
12 (2): R42, 2008.
9. Rosen S, Heyman SN: Difficulties in understanding human “acute tubular necrosis”: limited data and flawed animal models. Kidney Int
60 (4): 1220–1224, 2001.
10. Brenner M, Schaer GL, Mallory DL, Suffredini AF, Parrillo JE: Detection of renal blood flow abnormalities in septic and critically ill patients using a newly designed indwelling thermodilution renal vein catheter. Chest
98 (1): 170–179, 1990.
11. Di Giantomasso D, Bellomo R, May CN: The haemodynamic and metabolic effects of epinephrine in experimental hyperdynamic septic shock. Intensive Care Med
31 (3): 454–462, 2005.
12. Di Giantomasso D, May CN, Bellomo R: Vital organ blood flow during hyperdynamic sepsis
124 (3): 1053–1059, 2003.
13. Di Giantomasso D, May CN, Bellomo R: Norepinephrine and vital organ blood flow during experimental hyperdynamic sepsis
. Intensive Care Med
29 (10): 1774–1781, 2003.
14. Ravikant T, Lucas CE: Renal blood flow distribution in septic hyperdynamic pigs. J Surg Res
22 (3): 294–298, 1977.
15. Wan L, Bellomo R, May CN: The effect of normal saline resuscitation on vital organ blood flow in septic sheep. Intensive Care Med
32 (8): 1238–1242, 2006.
16. Wang Z, Holthoff JH, Seely KA, et al.: Development of oxidative stress in the peritubular capillary microenvironment mediates sepsis
-induced renal microcirculatory failure and acute kidney injury
. Am J Pathol
180 (2): 505–516, 2012.
17. Seely KA, Holthoff JH, Burns ST, et al.: Hemodynamic changes in the kidney in a pediatric rat model of sepsis
-induced acute kidney injury
. Am J Physiol Renal Physiol
301 (1): F209–F217, 2011.
18. De Backer D, Creteur J, Preiser JC, Dubois MJ, Vincent JL: Microvascular blood flow is altered in patients with sepsis
. Am J Respir Crit Care Med
166 (1): 98–104, 2002.
19. Singer M, De Santis V, Vitale D, Jeffcoate W: Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation
364 (9433): 545–548, 2004.
20. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis
. N Engl J Med
348 (2): 138–150, 2003.
21. Fry DE: Sepsis
, systemic inflammatory response, and multiple organ dysfunction: the mystery continues. Am Surg
78 (1): 1–8, 2012.
22. Kalakeche R, Hato T, Rhodes G, et al.: Endotoxin uptake by S1 proximal tubular segment causes oxidative stress in the downstream S2 segment. J Am Soc Nephrol
22 (8): 1505–1516, 2011.
23. Wu L, Gokden N, Mayeux PR: Evidence for the role of reactive nitrogen species in polymicrobial sepsis
-induced renal peritubular capillary dysfunction and tubular injury. J Am Soc Nephrol
18 (6): 1807–1815, 2007.
24. 24. De Backer D, Creteur J, Preiser J-C, Dubois M-J, Vincent J-L: Microvascular blood flow is altered in patients with sepsis
. 166: 98–104, 2002.
25. De Backer D, Donadello K, Taccone FS, Ospina-Tascon G, Salgado D, Vincent JL: Microcirculatory alterations: potential mechanisms and implications for therapy. Ann Intensive Care
1 (1): 27, 2011.
26. Verdant CL, De Backer D, Bruhn A, et al.: Evaluation of sublingual and gut mucosal microcirculation
: a quantitative analysis. Crit Care Med
37 (11): 2875–2881, 2009.
27. Tiwari MM, Brock RW, Megyesi JK, Kaushal GP, Mayeux PR: Disruption of renal peritubular blood flow in lipopolysaccharide-induced renal failure: role of nitric oxide and caspases. Am J Physiol Renal Physiol
289 (6): F1324–F1332, 2005.
28. Holthoff JH, Wang Z, Seely KA, Gokden N, Mayeux PR: Resveratrol improves renal microcirculation
, protects the tubular epithelium, and prolongs survival in a mouse model of sepsis
-induced acute kidney injury
. Kidney Int
81 (4): 370–378, 2012.
29. Dyson A, Bezemer R, Legrand M, Balestra G, Singer M, Ince C: Microvascular and interstitial oxygen tension in the renal cortex and medulla studied in a 4-h rat model of LPS-induced endotoxemia. Shock
36 (1): 83–89, 2011.
30. Almac E, Siegemund M, Demirci C, Ince C: Microcirculatory recruitment maneuvers correct tissue CO2
abnormalities in sepsis
. Minerva Anestesiol
72 (6): 507–519, 2006.
31. Schumacker PT, Chandel N, Agusti AG: Oxygen conformance of cellular respiration in hepatocytes. Am J Physiol
265 (4 Pt 1): L395–L402, 1993.
32. Cunha FQ, Assreuy J, Moss DW, et al.: Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: role of TNF-alpha and IL-1-beta. Immunology
81 (2): 211–215, 1994.
33. Trzeciak S, Cinel I, Phillip Dellinger R, et al.: Resuscitating the microcirculation
: the central role of nitric oxide, emerging concepts for novel therapies, and challenges for clinical trials. Acad Emerg Med
15 (5): 399–413, 2008.
34. Chauhan SD, Seggara G, Vo PA, Macallister RJ, Hobbs AJ, Ahluwalia A: Protection against lipopolysaccharide-induced endothelial dysfunction in resistance and conduit vasculature of iNOS knockout mice. FASEB J
17 (6): 773–775, 2003.
35. Heemskerk S, Masereeuw R, Russel FG, Pickkers P: Selective iNOS inhibition for the treatment of sepsis
-induced acute kidney injury
. Nat Rev Nephrol
5 (11): 629–640, 2009.
36. Goddard CM, Allard MF, Hogg JC, Herbertson MJ, Walley KR: Prolonged leukocyte transit time in coronary microcirculation
of endotoxemic pigs. Am J Physiol
269 (4 Pt 2): H1389–H1397, 1995.
37. Wu L, Tiwari MM, Messer KJ, et al.: Peritubular capillary dysfunction and renal tubular epithelial cell stress following lipopolysaccharide administration in mice. Am J Physiol Renal Physiol
292 (1): F261–F268, 2007.
38. Wu X, Guo R, Wang Y, Cunningham PN: The role of ICAM-1 in endotoxin-induced acute renal failure. Am J Physiol Renal Physiol
293 (4): F1262–F1271, 2007.
39. Bezemer R, Legrand M, Klijn E, et al.: Real-time assessment of renal cortical microvascular perfusion heterogeneities using near-infrared laser speckle imaging. Optics Expr
18 (14): 15054–15061, 2010.
40. Legrand M, Bezemer R, Kandil A, Demirci C, Payen D, Ince C: The role of renal hypoperfusion in development of renal microcirculatory dysfunction in endotoxemic rats. Intensive Care Med
37 (9): 1534–1542, 2011.
41. Brealey D, Brand M, Hargreaves I, et al.: Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet
360 (9328): 219–223, 2002.
42. Brealey D, Karyampudi S, Jacques TS, et al.: Mitochondrial dysfunction in a long-term rodent model of sepsis
and organ failure. Am J Physiol Regul Integr Comp Physiol
286 (3): R491–R497, 2004.
43. Brealey D, Singer M: Mitochondrial dysfunction in sepsis
. Curr Infect Dis Rep
5 (5): 365–371, 2003.
44. Yang QH, Liu DW, Long Y, Liu HZ, Chai WZ, Wang XT: Acute renal failure during sepsis
: potential role of cell cycle
regulation. J Infect
58 (6): 459–464, 2009.
45. Gupta A, Rhodes GJ, Berg DT, Gerlitz B, Molitoris BA, Grinnell BW: Activated protein C ameliorates LPS-induced acute kidney injury
and downregulates renal INOS and angiotensin 2. Am J Physiol Renal Physiol
293 (1): F245–F254, 2007.
46. Good DW, George T, Watts BA 3rd: Lipopolysaccharide directly alters renal tubule transport through distinct TLR4-dependent pathways in basolateral and apical membranes. Am J Physiol Renal Physiol
297 (4): F866–F874, 2009.
47. El-Achkar TM, Hosein M, Dagher PC: Pathways of renal injury in systemic gram-negative sepsis
. Eur J Clin Invest
38 (Suppl 2): 39–44, 2008.
48. El-Achkar TM, Huang X, Plotkin Z, Sandoval RM, Rhodes GJ, Dagher PC: Sepsis
induces changes in the expression and distribution of Toll-like receptor 4 in the rat kidney. Am J Physiol Renal Physiol
290 (5): F1034–F1043, 2006.
49. Ferraro E, Cecconi F: Autophagic and apoptotic response to stress signals in mammalian cells. Arch Biochem Biophys
462 (2): 210–219, 2007.
50. Green DR: The end and after: how dying cells impact the living organism. Immunity
35 (4): 441–444, 2011.
51. Atkinson D: Cellular Energy Metabolism and Its Regulation
. Atkinson D, ed. New York: Academic Press, pp. 218, 1977.
52. Buttgereit F, Brand MD: A hierarchy of ATP-consuming processes in mammalian cells. Biochem J
312 (Pt 1): 163–167, 1995.
53. Buck LT, Hochachka PW, Schon A, Gnaiger E: Microcalorimetric measurement of reversible metabolic suppression induced by anoxia in isolated hepatocytes. Am J Physiol
265 (5 Pt 2): R1014–R1019, 1993.
54. Carre JE, Singer M: Cellular energetic metabolism in sepsis
: the need for a systems approach. Biochim Biophys Acta
1777 (7–8): 763–771, 2008.
55. Vanhorebeek I, Gunst J, Derde S, et al.: Mitochondrial fusion, fission, and biogenesis in prolonged critically ill patients. J Clin Endocrinol Metab
97 (1): E59–E64, 2012.
56. Green DR, Galluzzi L, Kroemer G: Mitochondria
and the autophagy-inflammation
-cell death axis in organismal aging. Science
333 (6046): 1109–1112, 2011.
57. Waltz P, Carchman EH, Young AC, et al.: Lipopolysaccharide induces autophagic signaling in macrophages via a TLR4, heme oxygenase-1 dependent pathway. Autophagy
7 (3): 315–320, 2011.
58. Frank M, Duvezin-Caubet S, Koob S, et al.: Mitophagy is triggered by mild oxidative stress in a mitochondrial fission dependent manner. Biochim Biophys Acta
1823 (12): 2297–2310, 2012.
59. Wang Y, Nartiss Y, Steipe B, McQuibban GA, Kim PK: ROS-induced mitochondrial depolarization initiates PARK2/PARKIN-dependent mitochondrial degradation by autophagy. Autophagy
8 (10): 1462–1476, 2012.
60. Hsiao HW, Tsai KL, Wang LF, et al.: The decline of autophagy contributes to proximal tubular dysfunction during sepsis
37 (3): 289–296, 2012.
61. Gunst J, Derese I, Aertgeerts A, et al.: Insufficient autophagy contributes to mitochondrial dysfunction, organ failure, and adverse outcome in an animal model of critical illness. Crit Care Med
41 (1): 182–194, 2013.
62. Mizushima N, Levine B, Cuervo AM, Klionsky DJ: Autophagy fights disease through cellular self-digestion. Nature
451 (7182): 1069–1075, 2008.
63. Levine B, Yuan J: Autophagy in cell death: an innocent convict? J Clin Invest
115 (10): 2679–2688, 2005.
64. Ciechomska IA, Goemans CG, Tolkovsky AM: Molecular links between autophagy and apoptosis. Methods Mol Biol
445: 175–193, 2008.
65. Finkel T, Hwang PM: The Krebs cycle meets the cell cycle
and the G1-S transition. Proc Natl Acad Sci U S A
106 (29): 11825–11826, 2009.
66. Mitra K, Wunder C, Roysam B, Lin G, Lippincott-Schwartz J: A hyperfused mitochondrial state achieved at G1-S regulates cyclin E buildup and entry into S phase. Proc Natl Acad Sci U S A
106 (29): 11960–11965, 2009.
67. Schieke SM, McCoy JP Jr, Finkel T: Coordination of mitochondrial bioenergetics with G1 phase cell cycle
progression. Cell Cycle
7 (12): 1782–1787, 2008.
68. Mandal S, Guptan P, Owusu-Ansah E, Banerjee U: Mitochondrial regulation of cell cycle
progression during development as revealed by the tenured mutation in Drosophila
. Dev Cell
9 (6): 843–854, 2005.
69. Kashani K, Al-Khafaji A, Ardiles T, et al.: Discovery and validation of cell cycle
arrest biomarkers in human acute kidney injury
. Crit Care
17 (1): R25, 2013.
70. Singh P, Okusa MD: The role of tubuloglomerular feedback in the pathogenesis of acute kidney injury
. Contrib Nephrol
174: 12–21, 2011.
71. Boerma EC, Koopmans M, Konijn A, et al.: Effects of nitroglycerin on sublingual microcirculatory blood flow in patients with severe sepsis
/septic shock after a strict resuscitation protocol: a double-blind randomized placebo controlled trial. Crit Care Med
38 (1): 93–100, 2010.
72. de Backer D, Creteur J, Dubois MJ, et al.: The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects. Crit Care Med
34 (2): 403–408, 2006.
73. de Backer D, Verdant C, Chierego M, Koch M, Gullo A, Vincent JL: Effects of drotrecogin alfa activated on microcirculatory alterations in patients with severe sepsis
. Crit Care Med
34 (7): 1918–1924, 2006.
74. Pleiner J, Mittermayer F, Schaller G, MacAllister RJ, Wolzt M: High doses of vitamin C reverse Escherichia coli
endotoxin-induced hyporeactivity to acetylcholine in the human forearm. Circulation
106 (12): 1460–1464, 2002.
75. Tyml K, Li F, Wilson JX: Delayed ascorbate bolus protects against maldistribution of microvascular blood flow in septic rat skeletal muscle. Crit Care Med
33 (8): 1823–1828, 2005.
76. de Caterina R, Libby P, Peng HB, et al.: Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest
96 (1): 60–68, 1995.
77. Goldfarb RD, Cinel I: Inhaled nitric oxide therapy for sepsis
: more than just lung. Crit Care Med
35 (1): 290–292, 2007.
78. Howell GM GH, Collage RD, Loughran P, Escobar D, Zhang X, Billiar TR, Zuckerbraun BS, Rosengart MR: Augmenting autophagy to treat acute kidney injury
during endotoxemia in mice. PLoS One
8 (7): e69520, 2013.
79. Bonventre JV, Yang L: Cellular pathophysiology of ischemic acute kidney injury
. J Clin Invest
121 (11): 4210–4221, 2011.